Established 1999
123jump.com - U.S. Financial Information Archive: 90,000 Annual and 10-K reports – 20,000 Global news stories - 3,500 IPO reports - 1,700 - Earnings Calls – 320 Fund Interviews – 10-year Annual earnings on 4,500 stocks – 20 Quarterly earnings on 3,600 stocks – 1,800 IPO prospectuses – 1,200 Economic data releases
     
   
 

Alcon Inc.(ACL)

 
123Jump Rating: - Long-Term Growth   Underwriters: CS First Boston
      Merrill Lynch & Co.
Status: Priced   Goldman, Sachs & Co.
 
Address: Bösch 69 CH-6331 Hünenberg,
 FiledDate: 02/22/2002
  Zug,
    
  Switzerland
 Filed Price Range ($): $31.00-35.00
       
Telephone: +41-41-785-88-88 Filed Offer Amount ($ Million): $2301.75
       
Fax: Shares Offered (Millions): 70
       
Websites: www.alconlabs.com Shares Outstanding (Millions): 300
       
Management: Cary Rayment, Chair./Pres./CEO
 IPO Date: 03/20/2002
  Jacqualyn Fouse, SVP/CFO
    
  Doug MacHatton, VP
 Final Offer Price ($): $33.00
       
Industry: Healthcare Final Offer Size (Millions of Shares): 70.00
       
Employees: 11,000 Final Offer Amount ($ Million): $2,310.00
       
Competitors: Allergan
 S-1 Forms:
  Bausch & Lomb
    
  Novartis
  
       
     
     
     
       
 
- Avoid        - Value Gap        - Short-Term Growth        - Long-Term Growth        - Long-Term Value

Company Links
Executives Products Services
Income Data 
Year Revenues Costs Oper Income Taxes Net Income EPS
1999 2401 719.1 617.2 240.3 346.9 1.22
2000 2553.6 749.7 596.8 223 331.7 1.11
2001 2747.7 798.3 588.9 198.3 315.6 1.05
 
 
© 1999-2008 123jump.com. All rights reserved